First human tests for new hay fever drug
Disease control
Completed
This early-stage study tested the safety of a new drug called INI-2004 for people with ragweed allergies (hay fever). First, healthy volunteers received single doses. Then, people with confirmed ragweed allergies received multiple weekly doses. The main goal was to check for side…
Phase: PHASE1 • Sponsor: Inimmune Corporation • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC